1
TANGO THERAPEUTICS INC
COM
TNGX
TNGX
10,876,219
$340.0m25.61%
25.61%
Unchanged Shares held: Q3 2025 9.8m, Q4 2025 10.9m, Q1 2026 10.9m, Q2 2026 10.9m
2
REVOLUTION MEDICINES INC
COM
RVMD
RVMD
500,000
$93.6m7.05%
7.05%
Unchanged Shares held: Q3 2025 400.0k, Q4 2025 400.0k, Q1 2026 500.0k, Q2 2026 500.0k
3
ABIVAX SA
SPONSORED ADS
ABVX
ABVX
605,000
$80.6m6.07%
6.07%
Added Shares held: Q3 2025 120.0k, Q4 2025 125.0k, Q1 2026 200.0k, Q2 2026 605.0k
+405.0k
+405,000
202.5%
4
UNIQURE NV
SHS
QURE
QURE
1,503,300
$69.2m5.21%
5.21%
Added Shares held: Q3 2025 800.0k, Q4 2025 290.0k, Q1 2026 662.0k, Q2 2026 1.5m
+841.3k
+841,300
127.1%
5
KODIAK SCIENCES INC
COM
KOD
KOD
1,477,600
$57.6m4.34%
4.34%
Added Shares held: Q3 2025 750.0k, Q4 2025 1.1m, Q1 2026 1.4m, Q2 2026 1.5m
+116.6k
+116,600
8.6%
6
KYMERA THERAPEUTICS INC
COM
KYMR
KYMR
429,100
$49.2m3.71%
3.71%
Added Shares held: Q3 2025 319.1k, Q4 2025 329.1k, Q1 2026 329.1k, Q2 2026 429.1k
+100.0k
+100,000
30.4%
7
DEFINIUM THERAPEUTICS INC
COM SHS
DFTX
DFTX
998,500
$47.0m3.54%
3.54%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 598.5k, Q2 2026 998.5k
+400.0k
+400,000
66.8%
8
REPLIMUNE GROUP INC
COM
REPL
REPL
3,983,000
$44.1m3.32%
3.32%
Added Shares held: Q3 2025 1.1m, Q4 2025 750.0k, Q1 2026 1.2m, Q2 2026 4.0m
+2.8m
+2,808,000
239.0%
9
CELCUITY INC
COM
CELC
CELC
416,530
$43.6m3.28%
3.28%
Added Shares held: Q3 2025 90.0k, Q4 2025 225.0k, Q1 2026 225.0k, Q2 2026 416.5k
+191.5k
+191,530
85.1%
10
Q32 BIO INC
COM
QTTB
QTTB
3,149,310
$40.1m3.02%
3.02%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.1m
11
CAPRICOR THERAPEUTICS INC
COM NEW
CAPR
CAPR
1,395,156
$33.6m2.53%
2.53%
Added Shares held: Q3 2025 0, Q4 2025 325.0k, Q1 2026 590.0k, Q2 2026 1.4m
+805.2k
+805,156
136.5%
12
PRECIGEN INC
COM
PGEN
PGEN
5,150,000
$29.4m2.21%
2.21%
Added Shares held: Q3 2025 850.0k, Q4 2025 1.4m, Q1 2026 3.5m, Q2 2026 5.2m
+1.6m
+1,650,000
47.1%
13
CORCEPT THERAPEUTICS INC
COM
CORT
CORT
335,500
$29.2m2.20%
2.20%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 250.0k, Q2 2026 335.5k
+85.5k
+85,500
34.2%
14
SURROZEN INC
COM NEW
SRZN
SRZN
1,105,683
$27.0m2.03%
2.03%
Added Shares held: Q3 2025 0, Q4 2025 416.1k, Q1 2026 766.3k, Q2 2026 1.1m
+339.4k
+339,365
44.3%
15
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
170,000
$20.8m1.57%
1.57%
Unchanged Shares held: Q3 2025 110.0k, Q4 2025 170.0k, Q1 2026 170.0k, Q2 2026 170.0k
16
VIR BIOTECHNOLOGY INC
COM
VIR
VIR
1,866,000
$19.0m1.43%
1.43%
Unchanged Shares held: Q3 2025 0, Q4 2025 625.0k, Q1 2026 1.9m, Q2 2026 1.9m
17
VAXCYTE INC
COM
PCVX
PCVX
325,000
$18.9m1.42%
1.42%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 325.0k, Q2 2026 325.0k
18
UROGEN PHARMA LTD
COM
URGN
URGN
500,000
$18.4m1.39%
1.39%
Unchanged Shares held: Q3 2025 575.0k, Q4 2025 500.0k, Q1 2026 500.0k, Q2 2026 500.0k
19
CORVUS PHARMACEUTICALS INC
COM
CRVS
CRVS
1,100,000
$16.4m1.24%
1.24%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.1m, Q2 2026 1.1m
20
PTC THERAPEUTICS INC
COM
PTCT
PTCT
200,000
$16.3m1.23%
1.23%
Unchanged Shares held: Q3 2025 200.0k, Q4 2025 200.0k, Q1 2026 200.0k, Q2 2026 200.0k
21
PRAXIS PRECISION MEDICINES I
COM NEW
PRAX
PRAX
46,457
$15.6m1.17%
1.17%
Unchanged Shares held: Q3 2025 0, Q4 2025 46.5k, Q1 2026 46.5k, Q2 2026 46.5k
22
AMYLYX PHARMACEUTICALS INC
COM
AMLX
AMLX
800,000
$14.4m1.08%
1.08%
Unchanged Shares held: Q3 2025 900.0k, Q4 2025 800.0k, Q1 2026 800.0k, Q2 2026 800.0k
23
OCULAR THERAPEUTIX INC
COM
OCUL
OCUL
1,300,000
$12.8m0.96%
0.96%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 350.0k, Q2 2026 1.3m
+950.0k
+950,000
271.4%
24
OPUS GENETICS INC
COM
IRD
IRD
2,815,000
$11.6m0.87%
0.87%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.2m, Q2 2026 2.8m
+565.0k
+565,000
25.1%
25
PALISADE BIO INC
COM
PALI
PALI
4,799,875
$10.0m0.76%
0.76%
Unchanged Shares held: Q3 2025 0, Q4 2025 4.8m, Q1 2026 4.8m, Q2 2026 4.8m
26
APOGEE THERAPEUTICS INC
COM
COM
70,000
$9.3m0.70%
0.70%
Unchanged Shares held: Q3 2025 50.0k, Q4 2025 70.0k, Q1 2026 70.0k, Q2 2026 70.0k
27
SPYRE THERAPEUTICS INC
COM NEW
SYRE
SYRE
100,000
$8.9m0.67%
0.67%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 100.0k
28
COGENT BIOSCIENCES INC
COM
COGT
COGT
225,000
$8.7m0.66%
0.66%
Unchanged Shares held: Q3 2025 0, Q4 2025 225.0k, Q1 2026 225.0k, Q2 2026 225.0k
29
CYTOKINETICS INC
COM NEW
CYTK
CYTK
100,000
$8.5m0.64%
0.64%
Unchanged Shares held: Q3 2025 200.0k, Q4 2025 100.0k, Q1 2026 100.0k, Q2 2026 100.0k
30
RELAY THERAPEUTICS INC
COM
RLAY
RLAY
450,000
$8.4m0.63%
0.63%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 450.0k
31
CRESCENT BIOPHARMA INC.
COM
COM
453,686
$8.2m0.62%
0.62%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 453.7k, Q2 2026 453.7k
32
CONTINEUM THERAPEUTICS INC
CL A
CTNM
CTNM
494,000
$8.1m0.61%
0.61%
Unchanged Shares held: Q3 2025 0, Q4 2025 494.0k, Q1 2026 494.0k, Q2 2026 494.0k
33
KAZIA THERAPEUTICS LTD
SPONSORED ADS
KZIA
KZIA
560,000
$7.9m0.59%
0.59%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 560.0k
34
SHATTUCK LABS INC
COM
STTK
STTK
1,000,000
$6.9m0.52%
0.52%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
35
AVALO THERAPEUTICS INC
COM NEW
AVTX
AVTX
375,000
$6.9m0.52%
0.52%
Added Shares held: Q3 2025 125.0k, Q4 2025 275.0k, Q1 2026 300.0k, Q2 2026 375.0k
+75.0k
+75,000
25.0%
36
FORTE BIOSCIENCES INC
COM NEW
FBRX
FBRX
274,500
$5.8m0.44%
0.44%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 274.5k
37
RELMADA THERAPEUTICS INC
COM
RLMD
RLMD
842,106
$5.8m0.44%
0.44%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 842.1k, Q2 2026 842.1k
38
MOONLAKE IMMUNOTHERAPEUTICS
CLASS A ORD
MLTX
MLTX
275,000
$5.4m0.40%
0.40%
Unchanged Shares held: Q3 2025 250.0k, Q4 2025 275.0k, Q1 2026 275.0k, Q2 2026 275.0k
39
ZURA BIO LTD
CLASS A ORD SHS
ZURA
ZURA
900,000
$5.3m0.40%
0.40%
Unchanged Shares held: Q3 2025 0, Q4 2025 50.0k, Q1 2026 900.0k, Q2 2026 900.0k
40
CYBIN INC
COM NEW
COM NEW
790,000
$5.2m0.39%
0.39%
Added Shares held: Q3 2025 0, Q4 2025 715.0k, Q1 2026 640.0k, Q2 2026 790.0k
+150.0k
+150,000
23.4%
41
ODYSSEY THERAPEUTICS INC
COMMON STOCK
ODTX
ODTX
275,000
$5.1m0.39%
0.39%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 275.0k
42
IMMATICS N.V
SHS
IMTX
IMTX
475,000
$4.8m0.36%
0.36%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 475.0k
43
FAETH THERAPEUTICS INC
COM NEW
FTH
FTH
180,505
$4.5m0.34%
0.34%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 180.5k
44
STRUCTURE THERAPEUTICS INC
SPONSORED ADS
GPCR
GPCR
75,000
$4.0m0.30%
0.30%
Unchanged Shares held: Q3 2025 0, Q4 2025 75.0k, Q1 2026 75.0k, Q2 2026 75.0k
45
ORIC PHARMACEUTICALS INC
COM
ORIC
ORIC
350,000
$3.8m0.29%
0.29%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 176.5k, Q2 2026 350.0k
+173.5k
+173,500
98.3%
46
AN2 THERAPEUTICS INC
COM
ANTX
ANTX
749,035
$3.6m0.27%
0.27%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 749.0k, Q2 2026 749.0k
47
NEUMORA THERAPEUTICS INC.
COM
NMRA
NMRA
2,000,000
$3.4m0.26%
0.26%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.0m
48
INOVIO PHARMACEUTICALS INC
COM SHS
INO
INO
2,844,994
$3.1m0.24%
0.24%
Added Shares held: Q3 2025 2.3m, Q4 2025 2.4m, Q1 2026 2.4m, Q2 2026 2.8m
+474.9k
+474,872
20.0%
49
ALLOGENE THERAPEUTICS INC
COM
ALLO
ALLO
1,500,000
$3.1m0.23%
0.23%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.7m, Q2 2026 1.5m
-1.2m
-1,225,000
-45.0%
50
SOLID BIOSCIENCES INC
COM NEW
SLDB
SLDB
300,000
$3.0m0.23%
0.23%
Unchanged Shares held: Q3 2025 600.0k, Q4 2025 300.0k, Q1 2026 300.0k, Q2 2026 300.0k
51
KARYOPHARM THERAPEUTICS INC
COM NEW
KPTI
KPTI
302,536
$3.0m0.22%
0.22%
Unchanged Shares held: Q3 2025 0, Q4 2025 252.5k, Q1 2026 302.5k, Q2 2026 302.5k
52
CLENE INC
COM NEW
CLNN
CLNN
477,515
$2.9m0.22%
0.22%
Unchanged Shares held: Q3 2025 0, Q4 2025 199.7k, Q1 2026 477.5k, Q2 2026 477.5k
53
SAREPTA THERAPEUTICS INC
COM
SRPT
SRPT
150,000
$2.7m0.20%
0.20%
Unchanged Shares held: Q3 2025 250.0k, Q4 2025 150.0k, Q1 2026 150.0k, Q2 2026 150.0k
54
MAPLIGHT THERAPEUTICS INC
COM
MPLT
MPLT
75,000
$2.7m0.20%
0.20%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 75.0k
55
NURIX THERAPEUTICS INC
COM
NRIX
NRIX
100,000
$2.4m0.18%
0.18%
Unchanged Shares held: Q3 2025 175.0k, Q4 2025 100.0k, Q1 2026 100.0k, Q2 2026 100.0k
56
LB PHARMACEUTICALS INC
COM SHS
LBRX
LBRX
70,000
$2.3m0.17%
0.17%
Unchanged Shares held: Q3 2025 70.0k, Q4 2025 70.0k, Q1 2026 70.0k, Q2 2026 70.0k
57
EDESA BIOTECH INC
COM NEW
EDSA
EDSA
205,000
$1.7m0.13%
0.13%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 205.0k
58
INVIVYD INC
COM
IVVD
IVVD
1,500,000
$1.3m0.10%
0.10%
Unchanged Shares held: Q3 2025 0, Q4 2025 1.5m, Q1 2026 1.5m, Q2 2026 1.5m
59
UPSTREAM BIO INC
COM
UPB
UPB
150,000
$1.0m0.08%
0.08%
Unchanged Shares held: Q3 2025 0, Q4 2025 150.0k, Q1 2026 150.0k, Q2 2026 150.0k
60
MILESTONE PHARMACEUTICALS IN
COM
MIST
MIST
666,666
$893.3k0.07%
0.07%
Unchanged Shares held: Q3 2025 666.7k, Q4 2025 666.7k, Q1 2026 666.7k, Q2 2026 666.7k
61
PEPGEN INC
COM
PEPG
PEPG
272,892
$491.2k0.04%
0.04%
Unchanged Shares held: Q3 2025 250.0k, Q4 2025 373.9k, Q1 2026 272.9k, Q2 2026 272.9k
62
REGENXBIO INC
COM
RGNX
RGNX
15,000
$179.7k0.01%
0.01%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 15.0k, Q2 2026 15.0k
63
SURROZEN INC
*W EXP 08/01/203
*W EXP 08/01/203
66,666
$1.1k0.00%
0.00%
Unchanged Shares held: Q3 2025 66.7k, Q4 2025 66.7k, Q1 2026 66.7k, Q2 2026 66.7k